Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02614287
What this trial is testing

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

Who this might be right for
Migraine
Eli Lilly and Company 270
Large-scale testing (Phase 3)Active Not RecruitingNCT04736706
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 1,854
Early research (Phase 1)Study completedNCT01495104
What this trial is testing

A Study on the Effects of Valproate on the Pharmacokinetics of RO4917838 in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 18
Testing effectiveness (Phase 2)Looking for participantsNCT06465433
What this trial is testing

Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab

Who this might be right for
Hematologic Malignancies
Incyte Corporation 25
Early research (Phase 1)Study completedNCT05383352
What this trial is testing

Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Ipsen 177
Early research (Phase 1)Ended earlyNCT03220347
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
Celgene 139
Not applicableStudy completedNCT01618747
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse

Who this might be right for
Glioblastoma Multiforme
Hoffmann-La Roche 20
Testing effectiveness (Phase 2)Study completedNCT03834948
What this trial is testing

AO-176 in Multiple Solid Tumor Malignancies

Who this might be right for
Solid Tumor
Arch Oncology 57
Not applicableEnded earlyNCT02144155
What this trial is testing

Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia

Who this might be right for
Schizophrenia
University of California, San Diego 14
Early research (Phase 1)Study completedNCT02723955
What this trial is testing

Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

Who this might be right for
Neoplasms
GlaxoSmithKline 829
Early research (Phase 1)Study completedNCT00849485
What this trial is testing

Levetiracetam 750 mg Tablets Under Non-Fasting Conditions

Who this might be right for
Healthy
Teva Pharmaceuticals USA 22
Post-approval studies (Phase 4)Looking for participantsNCT07142343
What this trial is testing

Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age With a Rare Disease Called CHAPLE (Complement Hyperactivation, Angiopathic Thrombosis, Protein-losing Enteropathy) Disease

Who this might be right for
CHAPLE Disease
Regeneron Pharmaceuticals 5
Large-scale testing (Phase 3)Study completedNCT01151098
What this trial is testing

Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study

Who this might be right for
Chronic Nonmalignant Pain
Purdue Pharma LP 189
Testing effectiveness (Phase 2)Study completedNCT02807363
What this trial is testing

Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers

Who this might be right for
Endometriosis
Enteris BioPharma Inc. 35
Not applicableStudy completedNCT01090063
What this trial is testing

Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis

Who this might be right for
Moderate to Severe Palmar Plantar Psoriasis
Tufts Medical Center 26
Early research (Phase 1)Study completedNCT00542763
What this trial is testing

Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome

Who this might be right for
Primary Sjogren's Syndrome
University Hospital Muenster 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06561321
What this trial is testing

Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma

Who this might be right for
Palmoplantar Keratoderma
Indiana University 6
Large-scale testing (Phase 3)Study completedNCT03512314
What this trial is testing

Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label Extension

Who this might be right for
XIAP DeficiencyNLRC4-MAS
AB2 Bio Ltd. 11
Large-scale testing (Phase 3)Study completedNCT03571516
What this trial is testing

Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome

Who this might be right for
Short Bowel Syndrome
Shire 10
Large-scale testing (Phase 3)Study completedNCT02872116
What this trial is testing

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma
Bristol-Myers Squibb 2,031
Next Page